Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19

Bibliographic Details
Title: Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19
Authors: Max Ruge, Joanne Michelle D. Gomez, Jeanne du Fay de Lavallaz, Alexander Hlepas, Annas Rahman, Priya Patel, Clay Hoster, Prutha Lavani, Gatha G. Nair, Nusrat Jahan, J. Alan Simmons, Anupama K. Rao, William Cotts, Kim Williams, Annabelle Santos Volgman, Karolina Marinescu, Tisha Suboc
Source: American Heart Journal Plus, Vol 4, Iss , Pp 100022- (2021)
Publisher Information: Elsevier, 2021.
Publication Year: 2021
Collection: LCC:Diseases of the circulatory (Cardiovascular) system
Subject Terms: Heart failure, Mortality/survival, Complications, COVID-19, Diseases of the circulatory (Cardiovascular) system, RC666-701
More Details: Background: In the coronavirus disease 2019 (COVID-19) global pandemic, patients with cardiovascular disease represent a vulnerable population with higher risk for contracting COVID-19 and worse prognosis with higher case fatality rates. However, the relationship between COVID-19 and heart failure (HF) is unclear, specifically whether HF is an independent risk factor for severe infection or if other accompanying comorbidities are responsible for the increased risk. Methods: This is a retrospective analysis of 1331 adult patients diagnosed with COVID-19 infection between March and June 2020 admitted at Rush University System for Health (RUSH) in metropolitan Chicago, Illinois, USA. Patients with history of HF were identified by International Classification of Disease, Tenth Revision (ICD-10) code assignments extracted from the electronic medical record. Propensity score matching was utilized to control for the numerous confounders, and univariable logistic regression was performed to assess the relationship between HF and 60-day morbidity and mortality outcomes. Results: The propensity score matched cohort consisted of 188 patients in both the HF and no HF groups. HF patients did not have lower 60-day mortality (OR 0.81; p = 0.43) compared to patients without HF. However, those with HF were more likely to require readmission within 60 days (OR 2.88; p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2666-6022
Relation: http://www.sciencedirect.com/science/article/pii/S2666602221000203; https://doaj.org/toc/2666-6022
DOI: 10.1016/j.ahjo.2021.100022
Access URL: https://doaj.org/article/bdb456911f8147e28b9f4cdff6073d37
Accession Number: edsdoj.bdb456911f8147e28b9f4cdff6073d37
Database: Directory of Open Access Journals
More Details
ISSN:26666022
DOI:10.1016/j.ahjo.2021.100022
Published in:American Heart Journal Plus
Language:English